Chamath Palihapitiya to take Clover Well being public in one other SPAC deal price $3.7 billion
Chamath Palihapitiya has discovered his subsequent SPAC goal — Clover Well being, a Medicare insurance coverage start-up backed by Alphabet.
Clover will go public by way of a merger with Social Capital Hedosophia Holdings Corp. III, a particular function acquisition firm. The deal values Clover at $3.7 billion and consists of as much as $1.2 billion in money proceeds, $400 million of which might be supplied by a Palihapitiya-led non-public funding within the public entity.
“What we’ve is a enterprise that is really delivering the promise of technology-improving, higher outcomes and decrease value well being care,” Palihapitiya mentioned on CNBC’s “Squawk Field” on Tuesday. It is “a market that I believe is large and rising shortly” and a enterprise “that’s constantly taking share yr over yr over yr.”
“This is without doubt one of the most easy investments I’ve ever made,” Palihapitiya mentioned. He added by 2023 the corporate may have total profitability.
The transfer got here simply three weeks after Palihapitiya unveiled his $4.eight billion SPAC cope with actual property start-up Opendoor. The billionaire gained success together with his first blank-check transaction that took space-tourism firm Virgin Galactic public final yr and has been significantly energetic within the SPAC world in 2020. Palihapitiya beforehand revealed he has reserved tickers from “IPOA” by “IPOZ” on the New York Inventory Change.
Based in 2013, Clover sells Medicare Benefit within the U.S. and at the moment has greater than 57,000 members throughout seven states. The deal will present “important capital” for the corporate to “scale and enhance well being outcomes for seniors throughout the USA,” the corporate mentioned in an announcement on Tuesday.
A SPAC is fashioned to boost funds to finance a merger or acquisition sometimes inside two years. The goal agency might be taken public by the acquisition.
As a substitute for conventional IPOs, SPACs have skilled explosive development this yr amid unprecedented volatility introduced on by the coronavirus pandemic. Complete proceeds from SPACs have exceeded $40 billion this yr, almost tripling the degrees from a yr in the past and on observe for a report yr, in response to Refinitiv.
Many buyers and corporations flip to the SPAC route for its time effectivity in addition to certainty of execution. Corporations may skip the roadshow course of and keep away from among the scrutiny that goes with a standard IPO. Involvement from high-profile buyers together with hedge fund billionaire Invoice Ackman and Oakland A’s government Billy Beane introduced extra hype to this automobile.
Palihapitiya mentioned final month that the SPAC growth is wholesome for the general market that’s shrinking by variety of shares and is extremely concentrated in megacap know-how names.
Subscribe to CNBC PRO for unique insights and evaluation, and reside enterprise day programming from all over the world.